In addition to her law practice, Rachel is a voting member of the NYU Langone Medical Center IRB (ethics committee overseeing clinical research), and she also sits on the Advisory Board of the Orenova Group, LLC, a pharmaceutical drug development company. Rachel presents frequently at industry conferences on clinical research, healthcare and HIPAA compliance and has published articles on HIPAA in clinical research and legal issues surrounding Phase IV studies.
Rachel is a graduate of the Michlala Leminhal School of Law in Israel (LL.B., 1995) and the University of San Diego School of Law (LL.M.C., 2000). She is admitted to practice in New York, California (inactive) and Israel (inactive). She is fluent in Hebrew and English and is studying Arabic.